Dr. Prantesh Jain, MD
Claim this profileRoswell Park Comprehensive Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
4 reported clinical trials
7 drugs studied
Affiliated Hospitals
Roswell Park Comprehensive Cancer Center
Roswell Park Cancer Institute
Clinical Trials Prantesh Jain, MD is currently running
CIMAvax Vaccine + Nivolumab + Pembrolizumab
for Non-small Cell Lung Cancer and Squamous Head and Neck Cancer
This trial is testing a combination of a cancer vaccine (CIMAvax) and immune-boosting drugs (nivolumab and pembrolizumab). CIMAvax has shown promising results in lung cancer patients, while nivolumab and pembrolizumab have significantly improved overall survival in various cancers. It targets patients with advanced lung and head/neck cancers that have spread. The treatment works by enhancing the immune system's ability to fight cancer.
Recruiting1 award Phase 1 & 215 criteria
HPN328 + Atezolizumab
for Small Cell Lung Cancer
This trial is testing a new drug, HPN328, alone and with another drug, Atezolizumab, in patients with advanced cancers that have a specific protein called DLL3. The goal is to see if these treatments can help the immune system find and destroy cancer cells. This is aimed at patients whose cancers are hard to treat with standard therapies.
Recruiting1 award Phase 1 & 25 criteria
More about Prantesh Jain, MD
Clinical Trial Related8 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Prantesh Jain, MD has experience with
- CIMAvax Vaccine
- Nivolumab
- Pembrolizumab
- Predictive Models
- Nab-sirolimus
- Atezolizumab
Breakdown of trials Prantesh Jain, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Prantesh Jain, MD specialize in?
Prantesh Jain, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved DLL3 positive patients, or patients who are undergoing treatment.
Is Prantesh Jain, MD currently recruiting for clinical trials?
Yes, Prantesh Jain, MD is currently recruiting for 2 clinical trials in Buffalo New York. If you're interested in participating, you should apply.
Are there any treatments that Prantesh Jain, MD has studied deeply?
Yes, Prantesh Jain, MD has studied treatments such as CIMAvax Vaccine, Nivolumab, Pembrolizumab.
What is the best way to schedule an appointment with Prantesh Jain, MD?
Apply for one of the trials that Prantesh Jain, MD is conducting.
What is the office address of Prantesh Jain, MD?
The office of Prantesh Jain, MD is located at: Roswell Park Comprehensive Cancer Center, Buffalo, New York 14203 United States. This is the address for their practice at the Roswell Park Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.